ANIS AHMED KHAN



Salutation
Dr

School/Centre
School of Medicine

Department
Internal Medicine

Position
Senior Lecturer




Education

a
Certification Essentials of Imaging Science and Technology (Essentials of Imaging Science and Technology), 2022 Medical and Educational Academy Cardiff UK
a
PGHPE -Post Graduate Certificate Health Professional Education (Health Professional Education), 2019 International Medical University Malaysia
a
Certification License for Hemodialysis (Dialysis in Nephrology), 2018 MSM And MOH
a
Post Graduate Diploma Teaching (Education), 2013 Open University Malaysia
a
MRCP-Membership (Internal Medicine), 2005 Royal College of Physicians Ireland
a
Fellow College of Physicians and Surgeons Pakistan (Internal Medicine), 2002 College of Physicians and Surgeons Pakistan
a
Member College of Physicians and Surgeons Pakistan (Family Medicine), 1991 College of Physicians and Surgeons Pakistan
a
MBBS (Graduate Medicine & Surgery), 1985 Karachi University

Memberships

a
College of Physician Malaysia | National | Fellowship life time
a
Academy of Medicine Malaysia | National | Member
a
Malaysian Society Of Nephrology | National | Associate Member

Research Funding
a
Barriers towards Practice of Organ Donation in the General Population: A Systematic Review in Malaysia IMU Internal Research Grant | 2024-06-27 - 01 Mar 2025
a
Knowledge, attitude and practices of dengue patient admitted to Hospital Tuanku Ja’afar, Seremban, Malaysia IMU Internal Research Grant | 2022-09-08 - 02 Feb 2024

Publications

Research Articles

a
Population Pharmacokinetic Modeling of Cotadutide: A Dual Agonist Peptide of Glucagon-Like Peptide and Glucagon Receptors Administered to Participants with Type II Diabetes Mellitus, Chronic Kidney Disease, Obesity and Non-Alcoholic Steatohepatitis CLINICAL PHARMACOKINETICS | 2024
a
1249P Older patients experience similar toxicity and survival outcomes to FLOT chemotherapy compared to younger patients ANNALS OF ONCOLOGY | 2022
a
Single-dose nirsevimab for prevention of RSV in preterm infants NEW ENGLAND JOURNAL OF MEDICINE | 2020
a
Safety, tolerability and pharmacokinetics of MEDI8897, an extended half-life single-dose respiratory syncytial virus prefusion F-targeting monoclonal antibody administered as a single dose to healthy preterm infants THE PEDIATRIC INFECTIOUS DISEASE JOURNAL | 2018
a
Safety, efficacy and pharmacodynamics (PD) of MEDI9447 (oleclumab) alone or in combination with durvalumab in advanced colorectal cancer (CRC) or pancreatic cancer (panc). JOURNAL OF CLINICAL ONCOLOGY | 2018
a
Safety, tolerability, and pharmacokinetics of MEDI8897, the respiratory syncytial virus prefusion F-targeting monoclonal antibody with an extended half-life, in healthy adults ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2017
a
A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants SCIENCE TRANSLATIONAL MEDICINE | 2017
a
PCN36 Epoetin Alfa and Darbepoetin Alfa Dosing Patterns and Costs in Chemotherapy-Induced Anemia Inpatients VALUE IN HEALTH | 2012
a
Serology based disease status of Pakistani population infected with Hepatitis B virus BMC INFECTIOUS DISEASES | 2007
a
Breast cancer resistance protein (Bcrp/abcg2) is a major determinant of sulfasalazine absorption and elimination in the mouse MOLECULAR PHARMACEUTICS | 2006
a
Use of palonosetron 0.25 mg IV daily and incidence of nausea and vomiting in patients undergoing bone marrow transplantation (BMT) JOURNAL OF CLINICAL ONCOLOGY | 2006
a
In vivo activities of farnesyl pyrophosphate synthase inhibitors against Leishmania donovani and Toxoplasma gondii ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2002
a
Antimalarial, antiviral, and antitoxoplasmosis norsesterterpene peroxide acids from the Red Sea sponge Diacarnus erythraeanus JOURNAL OF NATURAL PRODUCTS | 2001
a
Pharmacokinetic studies of 13-cis-retinoic acid in pediatric patients with neuroblastoma following bone marrow transplantation CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1996
a
Pharmacokinetic and pharmacodynamic evaluations of 13-cis-retinoic acid in neuroblastoma in preclinical and clinical studies. N/A | 1995
a
Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation. JOURNAL OF CLINICAL ONCOLOGY | 1995
a
Hypercalcemia: a dose-limiting toxicity associated with 13-cis-retinoic acid JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY | 1993
a
Groundwater toxicity reduction evaluation 14 TH ANNUAL MEETING(SETAC)- ECOLOGICAL RISK ASSESSMENT: LESSONS LEARNED?-- ABSTRACT BOOK. VP. 1993. | 1993
a
Phase I trial of 13-cis-retinoic acid (cis-RA) in neuroblastoma patients following bone marrow transplantation (BMT) PROC. AM. SOC. CLIN. ONCOL | 1992
a
The treatability approach to toxicity reduction evaluations: a case study 13 TH ANNUAL MEETING SOCIETY OF ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY- ABSTRACTS. VP. 1992. | 1992

Other Publications

a
An electronic reminder as part of an educational intervention improves compliance with postoperative nausea and vomiting prophylaxis guidelines in ambulatory surgery patients. ANAESTHESIA | 01 Jan 2013